Slingshot Bio develops engineered synthetic cells to assist with complex research, utilizing hydrogel-based synthetic cells, known as FlowCytes.

Slingshot Bio

Viewport Meta

IPhone / Mobile Compatible

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Analytics

DNSSEC

Content Delivery Network

WordPress

Global Site Tag

Co-Founder & VP

Anh-Tuan Nguyen

Co-Founder & CEO/President

Jeff Kim

Vice President of Legal

Allan Kiang

Vice President, Finance

Dan Douglas

Vice President of Sales

John Scott

Marketing and Product

Marsha Hartman

Vice President Manufacturing Operations

Rachna Sehgal

Vice President of Slingshot Dx

Tam Truong

Director of Application Science

Andreas (Jack) Panopoulos

Director of Process Engineering and NPI

Brandon Miller

William (Bill) Hyun

Corey Ritter

Adam Wieschhaus

Co-Founder, CEO, and President

Tiffany Salas- Morris

Jeremy Agresti

Co-Founder

Co-Founder and Director of Business Development and Commercialization

Medical Early Stage Companies With Less Than $500M in Revenue

United States Companies With More Than 50 Employees (Top 10K)

Companies With Less Than $50M in Revenue (Top 10K)

Biotechnology Companies With Less Than $500M in Revenue (Top 10K)

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics. The company aims to bring simple, elegant, and cost-effective solutions to common problems facing research and development programs.

ARCH Venture Partners

Northpond Ventures

Series A - Slingshot Biosciences

Emeryville

California

United States

North America

Slingshot Biosciences

Tiffany Salas-Morris Joins Slingshot Biosciences as Chief Commercial Officer

Slingshot Unveils a Novel Cell Therapy-Focused Portfolio to Streamline Development while Improving Manufacturing ...

Slingshot Biosciences on LinkedIn: #hiring

Slingshot Biosciences Announces Election of Nicolas Barthelemy as Executive Chair

Hydrogel particles as feeder cells and as synthetic antigen presenting cells

Hydrogel particles with tunable optical properties and methods for using the …

Compositions and methods for single well multiplexed calibration and …

Slingshot Biosciences Unveils Revolutionary Fluorescent Protein Control Series to Enhance Flow Cytometry Analysis

Hydrogel-based synthetic cells designed for use in diagnostics and therapeutics, mimicking real cell properties.

Synthetic cell lines engineered with specific biomarkers for immunophenotyping and rare disease applications.

Controls designed for spectral flow cytometry, offering cell-like autofluorescence for signal-to-noise optimization.

Cell viability controls that simulate the staining properties of live cells for assay development.

Customizable synthetic cells tailored to specific research needs, including rare phenotypes and assay performance enhancement.

Services and products for cell analysis, including flow cytometry and hematology, leveraging synthetic cell technology for improved accuracy and consistency.

India

Asia

Czech Republic

Europe

HTML5

Wordpress

Lead Flows

F5 NGINX

GoDaddy Premium DNS

DigiCert

HubSpot Marketing Hub

Google Fonts

Bootstrap

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 1:54 PM	b822250a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 1:54 PM	069435d7
crunchbase trigger	general	Nov 19, 2024 1:54 PM	60c5e6c9
crunchbase profile	general	Nov 20, 2024 10:44 AM	a2fbf791
li profile	general	Nov 19, 2024 1:54 PM	41be6a58
translate crunchbase fundingrounds	general	Nov 20, 2024 11:07 AM	c98d52f8
peers	general	Nov 19, 2024 1:54 PM	edf21441
news basic	general	Nov 19, 2024 1:54 PM	df9eacf3
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

SLIN

COM:SLINGSHOTBIO

Slingshot Bio